Name | Heptadeca-1,9-dien-4,6-diyne-3,8-diol |
---|---|
Synonyms |
Falcarindiol
1,9-Heptadecadiene-4,6-diyne-3,8-diol, (3R,8S,9Z)- (3R,8S,9Z)-Heptadeca-1,9-diene-4,6-diyne-3,8-diol [R-[R*,S*-(Z)]]-19-Heptadecadiene-4,6-diyne-3,8-diol (3R,8S,9Z)-1,9-Heptadecadiene-4,6-diyne-3,8-diol |
Description | Falcarindiol, an orally active polyacetylenic oxylipin, activates PPARγ and increases the expression of the cholesterol transporter ABCA1 in cells. Falcarindiol induces apoptosis and autophagy. Falcarindiol has anti-inflammatory, antifungal, anticancer and antidiabetic properties[1][2]. |
---|---|
Related Catalog | |
Target |
PPARγ |
In Vitro | Falcarindiol (3, 6, 12, 24 µM; for 24 hours) significantly decreases cell viability of MDA-MB-231 and MDA-MB-468 cells. Cell viability of MCF-10A cells is unchanged until the dose of Falcarindiol reaches to 24 uM. Falcarindiol preferentially induces cell death in breast cancer cells[1]. Falcarindiol (6 uM; for 2 hours) induces autophagy and causes significant level of LC3-I converted to LC3-II in MDA-MB-231, MDA-MB-468 and SKBR3 cells[1]. Falcarindiol (6 uM; for 2, 4, 8, 24 hours) increases the level of GRP78 in MDA-MB-231 cells in dose- and time-dependent manner[1]. Falcarindiol (1-20 µM) has no effect on hMSCs and HT-29 cell viability. Falcarindiol with only concentrations above 50 µM exhibits a toxic effect on the cells[2]. Falcarindiol (5 µM; 10 min, 1 h and 24 h) causes a significant upregulation on PPARγ2 expression at 24 h[2]. |
In Vivo | Falcarindiol (7 µg/g; diet) increases ABCA1 expression in neoplastic tissue in five weeks old male rats[2]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 408.2±45.0 °C at 760 mmHg |
Molecular Formula | C17H24O2 |
Molecular Weight | 260.371 |
Flash Point | 184.7±23.3 °C |
Exact Mass | 260.177643 |
PSA | 40.46000 |
LogP | 6.32 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.524 |
Storage condition | 2-8C |